Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia
Completed · Phase 3
Conditions studied: Non-Hodgkin Lymphoma, Hodgkin Disease, Thrombocytopenia
In brief
Intensive chemotherapy is associated with significant thrombocytopenia, often requiring platelet transfusion to maintain platelet counts. This investigational drug has been demonstrated to increase platelet counts. This study will test the safety and efficacy of the investigational drug in the prevention of thrombocytopenia in patients with recurrent or refractory intermediate-grade or high-grade non-Burkitt's, non-Hodgkin's lymphoma (NHL), or Hodgkin's disease receiving DHAP (Dexamethasone, high-dose Cytarabine, and Cisplatin) chemotherapy.
Key facts
- Study ID
- NCT00039910
- Run by
- Pfizer
- People needed
- 240
- Starts
- 2000-07-01
- Expected to finish
- 2003-03-01
- Last updated by the study team
- 2007-05-04
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients must have recurrent or refractory intermediate-grade or high-grade non-Burkitt's, non-Hodgkin's lymphoma (NHL) or Hodgkin's disease and be scheduled for a minimum of 2 cycles of DHAP (Dexamethasone, high-dose Cytarabine and Cisplatin) chemotherapy
You may not qualify if…
- Patients must not have active bleeding (exclusions do apply) or history of platelet disorder
Where it is running
- Pfizer Investigational Site — Phoenix, Arizona, United States
- Pfizer Investigational Site — La Jolla, California, United States
- Pfizer Investigational Site — Loma Linda, California, United States
- Pfizer Investigational Site — Los Angeles, California, United States
- Pfizer Investigational Site — Los Angeles, California, United States
- Pfizer Investigational Site — Los Angeles, California, United States
- Pfizer Investigational Site — Los Angeles, California, United States
- Pfizer Investigational Site — Orange, California, United States
- Pfizer Investigational Site — Tamarac, Florida, United States
- Pfizer Investigational Site — Chicago, Illinois, United States
- Pfizer Investigational Site — Chicago, Illinois, United States
- Pfizer Investigational Site — Lake Charles, Louisiana, United States
- Pfizer Investigational Site — Detroit, Michigan, United States
- Pfizer Investigational Site — Saint Joseph, Michigan, United States
- Pfizer Investigational Site — Southfield, Michigan, United States
- Pfizer Investigational Site — Jefferson City, Missouri, United States
- Pfizer Investigational Site — Jefferson City, Missouri, United States
- Pfizer Investigational Site — Omaha, Nebraska, United States
- Pfizer Investigational Site — Brooklyn, New York, United States
- Pfizer Investigational Site — Durham, North Carolina, United States
- Pfizer Investigational Site — Coos Bay, Oregon, United States
- Pfizer Investigational Site — Hershey, Pennsylvania, United States
- Pfizer Investigational Site — Bristol, Tennessee, United States
- Pfizer Investigational Site — Abingdon, Virginia, United States
- Pfizer Investigational Site — Abingdon, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.